AAAAAA
Results:
1-21
|
Results: 21
Authors:
Bekersky, I
Fitzsimmons, W
Tanase, A
Maher, RM
Hodosh, E
Lawrence, I
Citation: I. Bekersky et al., Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitis, J AM ACAD D, 44(1), 2001, pp. S17-S27
Authors:
Lee, JW
Petersen, ME
Lin, P
Dressler, D
Bekersky, I
Citation: Jw. Lee et al., Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method, THER DRUG M, 23(3), 2001, pp. 268-276
Authors:
Bekersky, I
Fielding, RM
Dressler, DE
Kline, S
Buell, DN
Walsh, TJ
Citation: I. Bekersky et al., Pharmacokinetics, excretion, and mass balance of C-14 after administrationof C-14-cholesterol-labeled AmBisome to healthy volunteers, J CLIN PHAR, 41(9), 2001, pp. 963-971
Authors:
Bekersky, I
Dressler, D
Alak, A
Boswell, G
Mekki, QA
Citation: I. Bekersky et al., Comparative tacrolimus pharmacokinetics: Normal versus mildly hepatically impaired subjects, J CLIN PHAR, 41(6), 2001, pp. 628-635
Authors:
Bekersky, I
Dressler, D
Mekki, Q
Citation: I. Bekersky et al., Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose, J CLIN PHAR, 41(3), 2001, pp. 289-297
Authors:
Bekersky, I
Dressler, D
Mekki, QA
Citation: I. Bekersky et al., Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects, J CLIN PHAR, 41(2), 2001, pp. 176-182
Authors:
Townsend, RW
Zutshi, A
Bekersky, I
Citation: Rw. Townsend et al., Biodistribution of 4-[C-14]cholesterol-ambisome following a single intravenous administration to rats, DRUG META D, 29(5), 2001, pp. 681-685
Authors:
Groll, AH
Mickiene, D
Petraitis, V
Petraitiene, R
Ibrahim, KH
Piscitelli, SC
Bekersky, I
Walsh, TJ
Citation: Ah. Groll et al., Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits, ANTIM AG CH, 45(12), 2001, pp. 3322-3327
Authors:
Walsh, TJ
Goodman, JL
Pappas, P
Bekersky, I
Buell, DN
Roden, M
Barrett, J
Anaissie, EJ
Citation: Tj. Walsh et al., Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: Maximum tolerated dose study, ANTIM AG CH, 45(12), 2001, pp. 3487-3496
Authors:
Mancinelli, LM
Frassetto, L
Floren, LC
Dressler, D
Carrier, S
Bekersky, I
Benet, LZ
Christians, U
Citation: Lm. Mancinelli et al., The pharmacokinetics and metabolic disposition of tacrolimus: A comparisonacross ethnic groups, CLIN PHARM, 69(1), 2001, pp. 24-31
Authors:
Bekersky, I
Boswell, GW
Hiles, R
Fielding, RM
Buell, D
Walsh, TJ
Citation: I. Bekersky et al., Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome (R)): A 91-day study in rats, PHARM RES, 17(12), 2000, pp. 1494-1502
Authors:
Pirsch, J
Bekersky, I
Vincenti, F
Boswell, G
Woodle, ES
Alak, A
Kruelle, M
Fass, N
Facklam, D
Mekki, Q
Citation: J. Pirsch et al., Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: Pharmacokinetics and tolerability, J CLIN PHAR, 40(5), 2000, pp. 527-532
Authors:
Chen, HF
Peng, JZ
Luo, HY
Loubeau, M
Wan, XC
Xu, DS
Qi, SJ
Vu, MD
Daloze, P
Fitzsimmons, WE
Bekersky, I
Peets, J
Sehgal, SN
Wu, JP
Citation: Hf. Chen et al., Compromised kidney graft rejection response in vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus, TRANSPLANT, 69(8), 2000, pp. 1555-1561
Authors:
Qi, SJ
Xu, DS
Peng, JZ
Vu, MD
Wu, JP
Bekersky, I
Fitzsimmons, WE
Peets, J
Sehgal, S
Daloze, P
Chen, HF
Citation: Sj. Qi et al., Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey, TRANSPLANT, 69(7), 2000, pp. 1275-1283
Authors:
Bekersky, I
Fielding, RM
Buell, D
Lawrence, I
Citation: I. Bekersky et al., Lipid-based amphotericin B formulations: from animals to man, PHARM SCI T, 2(6), 1999, pp. 230-236
Authors:
Bekersky, I
Boswell, GW
Hiles, R
Fielding, RM
Buell, D
Walsh, TJ
Citation: I. Bekersky et al., Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome (R)) in beagle dogs, PHARM RES, 16(11), 1999, pp. 1694-1701
Authors:
Bekersky, I
Dressler, D
Mekki, QA
Citation: I. Bekersky et al., Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg, CLIN THER, 21(12), 1999, pp. 2058-2064
Authors:
Boswell, GW
Buell, D
Bekersky, I
Citation: Gw. Boswell et al., AmBisome (liposomal amphotericin B): A comparative review (vol 38, pg 583,1998), J CLIN PHAR, 39(4), 1999, pp. 428-428
Authors:
Bekersky, I
Buell, D
Boswell, G
Citation: I. Bekersky et al., ABELCET (R) treatment - Reply, J CLIN PHAR, 39(4), 1999, pp. 428-428
Authors:
Bekersky, I
Dressler, D
Colburn, W
Mekki, Q
Citation: I. Bekersky et al., Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design, J CLIN PHAR, 39(10), 1999, pp. 1032-1037
Authors:
Hebert, MF
Fisher, RM
Marsh, CL
Dressler, D
Bekersky, I
Citation: Mf. Hebert et al., Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers, J CLIN PHAR, 39(1), 1999, pp. 91-96
Risultati:
1-21
|